^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

IFNG expression

i
Other names: IFNG , Interferon gamma
Entrez ID:
Related biomarkers:
Phase N/A
Kelly McMasters
Recruiting
Last update posted :
05/24/2024
Initiation :
11/03/2020
Primary completion :
07/31/2025
Completion :
07/31/2026
IFNG • TNFA • PTPRC • ITGAM
|
IFNG expression
|
Keytruda (pembrolizumab)
Phase 2
National Cancer Centre, Singapore
Recruiting
Last update posted :
05/01/2024
Initiation :
06/12/2019
Primary completion :
08/01/2024
Completion :
08/01/2024
IFNG
|
IFNG expression
|
Keytruda (pembrolizumab) • 5-fluorouracil • capecitabine • oxaliplatin
Phase 4
Theodor Bilharz Research Institute
Completed
Last update posted :
01/10/2024
Initiation :
12/12/2021
Primary completion :
04/20/2023
Completion :
09/10/2023
CD8 • IFNG • IL6 • IL10
|
IFNG expression
Phase 1
Abramson Cancer Center at Penn Medicine
Recruiting
Last update posted :
12/08/2023
Initiation :
04/24/2018
Primary completion :
12/31/2026
Completion :
12/31/2027
IFNG
|
IFNG expression
Phase 2
National Cancer Institute (NCI)
Active, not recruiting
Last update posted :
12/06/2023
Initiation :
06/05/2019
Primary completion :
09/30/2023
Completion :
10/22/2024
PD-L1 • IFNG • CD4
|
PD-L1 expression • IFNG expression
|
Tecentriq (atezolizumab) • glycosylated recombinant human interleukin-7 (CYT107)
Phase 2
Zarour, Hassane, MD
Active, not recruiting
Last update posted :
11/30/2023
Initiation :
01/10/2018
Primary completion :
09/30/2023
Completion :
09/30/2024
PD-1
|
IFNG expression
|
Keytruda (pembrolizumab) • Opdivo (nivolumab)
Phase N/A
Institut de cancérologie Strasbourg Europe
Recruiting
Last update posted :
09/22/2023
Initiation :
08/25/2023
Primary completion :
08/25/2029
Completion :
08/25/2029
IFNG
|
IFNG expression
Phase N/A
Poitiers University Hospital
Active, not recruiting
Last update posted :
08/04/2023
Initiation :
04/20/2021
Primary completion :
04/01/2028
Completion :
04/01/2028
CD8 • IFNG • IL2RA • CCR7 • ITGA4 • PRF1 • B3GAT1 • ISG20
|
CD8 expression • IFNG expression
Phase 1
University of California, Davis
Recruiting
Last update posted :
08/01/2023
Initiation :
06/02/2023
Primary completion :
06/02/2025
Completion :
12/01/2025
CD8 • IFNG • IL6 • IL2RA • CD4 • CD69 • IL2 • IL10 • LAMP1 • TGFB1 • FOXP3 • IL17A • ISG20
|
IFNG expression
Phase 2
Institut Bergonié
Recruiting
Last update posted :
03/01/2023
Initiation :
07/23/2021
Primary completion :
07/01/2023
Completion :
01/01/2025
MSI • IFNG
|
IFNG expression
|
Imfinzi (durvalumab) • Tazverik (tazemetostat)
Phase N/A
China Medical University Hospital
Recruiting
Last update posted :
02/08/2023
Initiation :
05/18/2020
Primary completion :
07/31/2023
Completion :
07/31/2023
IFNG • TNFA • IL2
|
IFNG expression • IL2 expression
Phase 2
Academisch Medisch Centrum - Universiteit van A...
Recruiting
Last update posted :
09/16/2022
Initiation :
11/05/2021
Primary completion :
05/01/2025
Completion :
11/04/2029
HER-2 • IFNG • MLH1 • MSH6 • MSH2
|
HER-2 positive • MSI-H/dMMR • HER-2 negative • IFNG expression
|
capecitabine • oxaliplatin • Zynyz (retifanlimab-dlwr)
Phase 2
Medical University of South Carolina
Completed
Last update posted :
12/13/2021
Initiation :
05/30/2017
Primary completion :
11/15/2021
Completion :
11/15/2021
CD8 • IFNG • CD4 • CD69 • ICOS • IL10 • GZMB • TGFB1 • FOXP3
|
CD8 expression • IFNG expression • IL2 expression
|
Opdivo (nivolumab)
Phase 1b/2
MedImmune LLC
Completed
Last update posted :
06/09/2020
Initiation :
03/31/2015
Primary completion :
04/29/2019
Completion :
04/29/2019
PD-L1 • IFNG
|
IFNG expression • PD-L1-L
|
Imfinzi (durvalumab) • Imjudo (tremelimumab)
Phase 2
GlaxoSmithKline
Completed
Last update posted :
12/12/2017
Initiation :
07/14/2009
Primary completion :
04/26/2011
Completion :
03/21/2012
IFNG • TNFA • CD4 • IL2 • CD40LG
|
IFNG expression
Phase 1/2
Assistance Publique - Hôpitaux de Paris
Unknown status
Last update posted :
10/19/2017
Initiation :
01/01/2017
Primary completion :
05/01/2019
Completion :
05/01/2019
CD8 • IFNG • IL2RA • CD4 • FOXP3 • IL17A • ISG20
|
IFNG expression
|
cisplatin • docetaxel
Phase 1
Olivera Finn
Completed
Last update posted :
07/12/2016
Initiation :
06/01/2006
Primary completion :
01/01/2008
Completion :
12/01/2015
IFNG
|
IFNG expression
|
Hiltonol (poly-ICLC)